A comparative genome analysis of gene expression reveals different regulatory mechanisms between mouse and human embryo pre-implantation development by He, Kan et al.
He et al. Reproductive Biology and Endocrinology 2010, 8:41
http://www.rbej.com/content/8/1/41
Open Access RESEARCH
BioMed  Central
© 2010 He et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attri-
bution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Research A comparative genome analysis of gene expression 
reveals different regulatory mechanisms between 
mouse and human embryo pre-implantation 
development
KanHe1,2, Hongbo Zhao1,2, Qishan Wang1,2 and Yuchun Pan*1,2
Abstract
Background: Pre-implantation development is a crucial step in successful implantation and pregnancy in mammals. It 
has been studied in depth, but mostly in laboratory animal models. Less is known about the regulatory mechanism 
involved in the pre-implantation development in humans and about the comparative aspects.
Methods: Here, we employed the microarray datasets from the public database library of GEO and applied 
comparative analysis of genome wide temporal gene expression data based on statistical analysis and functional 
annotation for both mouse and human, demonstrating the discordance between the regulatory mechanisms of both 
mouse and human pre-implantation development.
Results: There were differences between mouse and human pre-implantation development both in the global gene 
expression pattern and in the expression changes of individual genes at each stage, including different major transient 
waves of transcription profiles and some stage-specific genes and significantly related pathways. There also appeared 
to be different functional changes from one stage to another between mouse and human.
Conclusions: The analysis presented here lead to interesting and complementary conclusions that the regulatory 
mechanism of human pre-implantation development is not completely the same as the mouse. Not as the fact that 1-
cell to 2-cell stage is important for mouse pre-implantation development, the 4-cell stage and 8-cell stage are both 
essential for human. Unlike in mouse, of which most of pathways found were related to energy, RNA and protein 
metabolism, the identified pathways in human were mostly disease-related and associated with human pre-
implantation embryonic development. All of these suggest that a further comparative analysis should be required for 
applying the result of mouse expression data to human research or therapy, particularly in pre-implantation 
developments. Our study provides several potential targets of genes and pathways for studying the regulatory 
mechanism of human pre-implantation development using mouse model.
Background
Pre-implantation development is a mammalian-specific
occurrence, which encompasses the period from fertiliza-
tion to implantation and involves a number of important
events [1]. Understanding pre-implantation develop-
ment is important, both for basic reproductive biology
and for practical applications including regenerative
medicine and livestock production. However, due to the
s c a r c i t y  o f  t h e  m a t e r i a l s ,  b o t h  i n  s i z e  ( a b o u t  0 . 1  m m
diameter) and in quantity (only a few to tens of oocytes
from each ovulation) are limited in related research,
which has hampered the molecular analysis of human
pre-implantation embryos. Thus using the mouse model
system has formed the current perfect paradigm about
gene expression during pre-implantation development.
Recently, more and more global gene expression profiles
during mouse pre-implantation development have been
examined, two principal transient waves of de novo tran-
scription have been identified [2,3]. Additionally, several
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important transcripts have been reported to have the
core roles at each developmental stage. For example,
H1foo and Msy2 have been reported as the oocyte-spe-
cific transcripts, which are not re-expressed later in
development, destruction of these maternal mRNAs
restricts the length of time that these genes can function
[4,5]; Recent studies have shown that JNK and p38 are
involved in cavity formation during pre-implantation
development [6,7]. As the unclear confidence of the pre-
viously identified genes, their roles in the regulation of
mouse pre-implantation development must be further
discussed and the consistence with human must also be
considered.
In our study, we employed time course expression data-
sets of early mouse and human embryo both from the
same series. Through our comparative analysis of
genome wide temporal gene expression data based on
significance analysis and functional annotation, we found
that there were many differences in the expression pat-
terns of pre-implantation development between mouse
and human, for both the regulatory waves and the identi-
fied genes.
Methods
Data collection
We searched GEO [8] for the gene expression profiling
studies related to pre-implantation development. Finally,
we chose the data set GSE18290 contributed by Xie D,
containing 52 samples of early bovine embryo, human
embryo, and mouse embryo [9]. As we were interested in
the mouse and human, we deleted 16 bovine samples.
There were 36 samples left, 18 for human (GSM456643 to
GSM456660) and 18 for mouse (GSM456661 to
GSM456678). Human and mouse embryos were har-
vested at successive stage from oocyte to blastocyst. They
were both generated at one-cell stage, two-cell stage,
four-cell stage, eight-cell stage, morula, and blastocyst,
the number of replication is 3. Total RNAs were
extracted, amplified and hybridized onto Affymetrix
microarrays. The platforms were Affymetrix Mouse
Expression 430A Array (MOE430A, total 22690 probe
sets) and Affymetrix Human Genome U133 Plus 2.0
Array (HG-U133_Plus_2, total 54675 probe sets).
Microarray data analysis
The datasets we chose (CEL files) were downloaded from
GSE18290. For mouse and human respectively, 18 sam-
ples were divided into 6 groups according to different
periods (the time condition). Probe intensities were then
normalized, and expression signals of all genes (probe
sets) were calculated using the Robust Multichip Averag-
ing (RMA) algorithm in affy package [10,11]. Statistical
analysis was performed by one-way ANOVA with a Ben-
jamini and Hochberg False Discovery Rate (BH-FDR =
0.05) for multiple testing correction followed by Tukey's
post-hoc tests [12]. Differentially expressed genes
between two neighbor stages were identified by 2.0 fold-
changes. Clustering on groups and genes was performed
based on the identified genes' expression using the
method of Hierarchical clustering. All of these processes
were performed using software packages developed in
version 2.4.0 of Bioconductor and R version 2.10.0
[10,13].
GO annotations and pathway analysis
Further classifications of GO annotations and pathway
analysis were performed by using the Database for Anno-
tation, Visualization and Integrated Discovery (DAVID)
[14,15], revealing over-represented function of identified
genes associated with developmental stages or time spec-
ification.
Results and Discussion
Global outlook by time-course analysis
Through our analysis by ANOVA-FDR test with False
Discovery Rate (FDR) ≤ 5%, 12930 probe sets were shown
statistically significant changes during mouse pre-
implantation development. By contrast, the number for
human was 21746. To identify the gene expression pat-
terns of these two species, we employed hierarchical clus-
tering on the samples' groups by using the above
identified genes and then had a comparison between
mouse and human (Figure 1). Obviously, there was differ-
ence between mouse and human transcription profiles.
For mouse, we identified two major transitions in the
gene expression patterns: one-cell stage to two-cell stage
and 4-cell stage to 8-cell stage. These transitions sepa-
rated mouse pre-implantation embryos into three phases:
one-cell stage (Mouse Phase 1); two-cell stage and 4-cell
stage (Mouse Phase 2); and 8-cell stage, morula and blas-
tocyst (Mouse Phase 3). The current microarray data
were mostly consistent with the previously reported
expression patterns of genes [2]. By contrast, for human,
there were also two major transitions, but they were: 4-
cell stage to 8-cell stage and 8-cell stage to morula. Simi-
larly, they separated human pre-implantation embryos
into three phases: one cell stage, two-cell stage and 4-cell
stage (Human Phase 1); 8-cell stage (Human Phase 2);
morula and blastocyst (Human Phase 3).
To obtain a perspective on global gene expression
changes, we performed a pair-wise comparison of gene
expression data for all pre-implantation developmental
stages. The threshold of Fold Change was 2.0. The results
for mouse and human are detailed in Table 1 and Figure
2. The lists of mouse and human significantly regulated
genes in each stage comparison can be seen in Additional
file 1 and 2, respectively. For mouse, there were two major
transient waves of gene expression changes. The firstHe et al. Reproductive Biology and Endocrinology 2010, 8:41
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wave was from one-cell stage to two-cell stage, the num-
ber of identified differently expressed probe sets was
totally 4316, including 1867 down-regulated and 2449
up-regulated. The second one was from 8-cell stage to
morula, a total of 3400 probe sets were identified, 819 for
down-regulated and 2581 for up-regulated. In compari-
son, only one major wave appeared in human expression
profiles, but the appearing periods focused on the later
stages. It was from 4-cell stage to 8-cell stage, total num-
ber is 7278 including 2180 down-regulated and 5098 up-
regulated. These found waves were mostly consistent
with the result of above hierarchical clustering, also
revealing different gene activations among pre-implanta-
tion developmental stages between mouse and human.
Our present finding suggests that in 1- and 2- cell
stages of humans, there are not many genes that get regu-
lated. But subsequently, numerous of the differentially
expressed genes have been identified in both 4-cell stage
and 8-cell stage, thus these two stages may play essential
roles in human pre-implantation development. The most
early and widely cited report has also shown that some of
the major qualitative changes which occur between the
four- and eight-cell stages are dependent on transcription
and cleavage is not sensitive to transcriptional inhibition
until after the four-cell stage [16]. Moreover, according to
more biological processes participating in Human Phase
3 (morula and blastocyst), it suggests that more prepara-
tions should be needed for implantation of human. On
the contrary, in the case of mouse though most of the
genes are regulated (up or down) between 1- and 2-cell
stages, there are fewer but essential genes up/down regu-
lated during later stages of pre-implantation develop-
ment. The transition from the two-cell to four-cell stage
is particularly important in pre-implantation mouse
embryonic development, as it involves transcriptional
reprogramming and cellular differentiation [17]. It is well
known that the transcriptome of the mammalian embryo
is comprised of maternally deposited transcripts after fer-
tilization, but maternal transcripts are degraded and
replaced by zygotic transcripts after several cell divisions,
the transition is called zygote genome activation (ZGA)
[2,3]. Our findings suggest that the timing of ZGA and
maternal transcripts degradation is different between
mice and human, it occurs between 1-cell and 2-cell stage
in mouse, but between 4-cell and 8-cell stage in human
development. They are supported by previous reports
[2,16,18].
Analysis of individual genes
In order to provide information about the expression
changes of individual genes over time, we further respec-
tively analyzed 12930 and 21746 statistically significant
genes by a k-means clustering method for mouse and
human pre-implantation development [19]. Although the
dynamics of actual gene expression changes of individual
genes was very complex, the k-means clustering provided
a good overview of expression trends and formed a wave-
like expression pattern. As a result, six clusters were iden-
tified respectively for mouse and human (Figure 3 and 4).
The significant genes from each cluster were shown in
Additional File 3 and 4. Several regulated genes specific
to each cluster were different between mouse and human.
For mouse, the identified 6 clusters can be assigned to
four main groups. The first group appears to represent
genes that showed a steady increase and decrease
throughout pre-implantation stages, including cluster 1
(containing 5749 probe sets) and cluster 2 (2197 probe
sets). In this group, it contains Esrra and Esrrb respec-
tively in cluster 2 and cluster 1, which have been reported
as associated with obesity and type 2 diabetes [20,21].
The second group appears to represent genes that
showed a dramatic decrease throughout the stages, abun-
dant in one cell stage but degraded during pre-implanta-
tion development, which is cluster 3 (1883 probe sets).
Figure 1 The comparison of Hierarchical clustering analysis on samples' groups between mouse and human. Hierarchical clustering analysis 
showed the similarity in transcription profiles among the samples tested for mouse and human [1,2,4,8], [M] and [B] denote the samples' groups of 
one-cell stage, two-cell stage, four-cell stage, eight-cell stage, morula and blastocyst, respectively.He et al. Reproductive Biology and Endocrinology 2010, 8:41
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The third group is exactly opposite to the second one, it
appears to represent genes that showed a dramatic
increase throughout the developmental stages, including
cluster 5 (690 probe sets). The last group includes cluster
4 (1721 probe sets) and cluster 6 (690 probe sets), the
genes here were firstly activated from one cell stage to 8-
cell stage, peaked at 8-cell stage but degraded at later
stages. In fact, the last group contains Mapk1 and Mapk3,
respectively in cluster 4 and cluster 6, which are both
well-known genes having central roles in diverse cellular
functions [22-25].
For human, these 6 clusters can also be divided into 4
groups. The first group appears to represent genes that
showed a steady increase and decrease through the
stages, except from 4-cell stage to 8-cell stage. The cluster
1 (containing 9169 probe sets) showed a dramatic
Figure 2 The trends of number of significantly regulated genes during pre-implantation development between mouse and human. Mouse 
and human trends of significantly regulated genes number during pre-implantation development are depicted by blue and red, respectively. X axis 
represents 5 different stage comparisons of pre-implantation development, including from 1-cell to 2-cell (1v2); from 2-cell to 4-cell (2v4); from 4-cell 
to 8-cell (4v8); from 8-cell to Morula (8 vM); from Morula to Blastocyst (MvB). Y axis represents the number of significantly regulated genes. The result 
is based on the data in Table 1.
Table 1: The comparisons of gene expression between embryo stages for mouse and human
FC ≥ 2.0 1 v 2 2 v 4 4 v 8 8 v M M v B
Mouse down 1867 1242 1233 819 1794
up 2449 691 1368 2581 140
Human down 10 375 2180 2423 1979
up 152 30 5098 1768 1532
1, 2, 4, 8, M and B denote one-cell stage, two-cell stage, four-cell stage, eight-cell stage, morula, and blastocyst, respectively. 1 v 2 represents 
the comparison of gene expression between one-cell stage and two-cell stage, down is for the down-regulated genes and up is for the up-
regulated genes. FC represents the threshold of Fold Changes = 2.0. The number represents the identified genes' count of each comparison 
for mouse and human.He et al. Reproductive Biology and Endocrinology 2010, 8:41
http://www.rbej.com/content/8/1/41
Page 5 of 15
increase from 4-cell stage to 8-cell stage, whereas the
cluster 2 (5751 probe sets) showed a dramatic decrease
during the period. In this group, there are our interesting
genes like ESR1 and ESR2. As in the mouse, The second
group appears to represent genes that showed a dramatic
decrease throughout the stages, abundant in one cell
stage but degraded during pre-implantation develop-
ment, which is cluster 4 (1907 probe sets). The third
group appears to represent genes that showed a dramatic
increase throughout the developmental stages, including
cluster 3 (2214 probe sets) and cluster 6 (894 probe sets).
The last group only includes cluster 5 (1811 probe sets),
also like the mouse, appearing to represent genes that
were firstly activated from one cell stage to 8-cell stage,
peaked at 8-cell stage but degraded at later stages. For
central genes, we also take the mitogen activated protein
kinase (MAPK) members for example. Mapk1 includes in
cluster 2, 3 and 5; there are Mapk7 in cluster 2, Mapk8 in
cluster 4, Mapk9  in cluster 3, Mapk12  in cluster 2,
Mapk13 in cluster 1 and Mapk14 in cluster5. Almost all
of MAPK members involve in the regulation of human
pre-implantation development.
During mouse pre-implantation development, the
exclusive expression of the Xist gene from the paternally
inherited allele is thought to play a role in the inactivation
of the paternally inherited X chromosome in the extra-
embryonic cell lineages of the developing female embryo.
The previous study using human cleavage-stage embryos
derived by in vitro fertilization revealed that a pattern of
XIST expression different from that in the mouse [26]. In
Figure 3 K-means clustering on significant genes for mouse. General trends of expression changes were analyzed by k-means clustering method 
for mouse. 6 clusters were classified and represented by different colors. X axis represents 6 different stages of pre-implantation development; y axis 
represents log intensities of individual genes.He et al. Reproductive Biology and Endocrinology 2010, 8:41
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our study, the profiles of XIST expression in both mouse
and human pre-implantation development were known.
As a result, the expression of Xist was significantly regu-
lated at mouse 2-cell stage and blastocyst, but almost sig-
nificantly regulated through human pre-implantation
development (from 2-cell to blastocyst). On the other
hand, in the k-means clustering of significant genes, the
mouse Xist gene was in Cluster 5 but the human XIST
gene was in Cluster 3. The details were shown in Addi-
tional file 1 and 2, colored in red. Thus, all of these dem-
onstrate that not as in the mouse, the pattern of human
XIST  expression is not consistent with a role for early
expression in the choice of paternal X inactivation but
participates in regulating the whole human early embryo
development.
Significantly related GO terms and pathways
We then sought to determine the functions associated
with the identified significant genes between each adja-
cent stage, analysis of over-represented annotations and
pathways were performed by using DAVID [14,15]. If p
value was less than 0.01, it was considered as significant
GO annotation or pathway. The significant GO terms of
over-represented genes were shown in Table 2 and 3
respectively for mouse or human. The significant path-
ways of over-represented genes were shown in Table 4
and 5 respectively for mouse or human.
With comparison to mouse, due to the less different
identified genes from one-cell stage to two-cell stage and
from two-cell stage to 4-cell stage for human, there were
less GO terms during these periods. The GO terms for
Figure 4 K-means clustering on significant genes for human. General trends of expression changes were analyzed by k-means clustering method 
for human. 6 clusters were classified and represented by different colors. X axis represents 6 different stages of pre-implantation development; y axis 
represents log intensities of individual genes.He et al. Reproductive Biology and Endocrinology 2010, 8:41
http://www.rbej.com/content/8/1/41
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Table 2: The over-represented classification of GO annotations for mouse identified genes
GO p value
1 v 2
(16)
GO:0044237~cellular metabolic process 1.29E-36
GO:0044238~primary metabolic process 1.10E-35
GO:0043170~macromolecule metabolic process 2.51E-31
GO:0006412~translation 1.47E-24
GO:0006396~RNA processing 7.26E-17
GO:0009058~biosynthetic process 1.11E-15
GO:0016043~cellular component organization and 
biogenesis
4.25E-10
GO:0033036~macromolecule localization 9.42E-10
GO:0045184~establishment of protein localization 2.45E-08
GO:0051236~establishment of RNA localization 7.03E-08
GO:0051649~establishment of cellular localization 1.81E-07
GO:0051641~cellular localization 1.94E-07
GO:0009719~response to endogenous stimulus 3.33E-07
GO:0007049~cell cycle 4.72E-06
GO:0007059~chromosome segregation 2.76E-05
GO:0022402~cell cycle process 2.74E-04
GO:0051301~cell division 2.08E-03
2 v 4
(13)
GO:0006412~translation 3.45E-25
GO:0044237~cellular metabolic process 2.41E-23
GO:0044238~primary metabolic process 3.32E-23
GO:0043170~macromolecule metabolic process 2.39E-20
GO:0009058~biosynthetic process 3.38E-15
GO:0006396~RNA processing 2.37E-09
GO:0045184~establishment of protein localization 4.15E-06
GO:0033036~macromolecule localization 5.72E-06
GO:0009056~catabolic process 2.71E-05
GO:0016043~cellular component organization and 
biogenesis
7.18E-05
GO:0051236~establishment of RNA localization 1.14E-03
GO:0051641~cellular localization 1.21E-03
GO:0051649~establishment of cellular localization 1.55E-03
4 v 8
(18)
GO:0044238~primary metabolic process 1.36E-12
GO:0044237~cellular metabolic process 6.67E-11
GO:0043170~macromolecule metabolic process 1.09E-10
GO:0016043~cellular component organization and 
biogenesis
1.02E-08
GO:0051301~cell division 3.26E-08
GO:0051641~cellular localization 9.22E-08
GO:0051649~establishment of cellular localization 2.26E-07
GO:0009058~biosynthetic process 2.41E-07
GO:0006412~translation 6.46E-06He et al. Reproductive Biology and Endocrinology 2010, 8:41
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GO:0006396~RNA processing 6.77E-06
GO:0007049~cell cycle 6.78E-06
GO:0033036~macromolecule localization 8.58E-06
GO:0045184~establishment of protein localization 2.35E-05
GO:0022402~cell cycle process 2.49E-05
GO:0009719~response to endogenous stimulus 1.82E-03
GO:0007059~chromosome segregation 3.13E-03
GO:0009056~catabolic process 3.62E-03
GO:0065009~regulation of a molecular function 7.05E-03
8 v M(17) GO:0044238~primary metabolic process 1.92E-32
GO:0044237~cellular metabolic process 1.80E-31
GO:0006396~RNA processing 4.57E-25
GO:0006412~translation 2.48E-24
GO:0043170~macromolecule metabolic process 2.54E-21
GO:0009058~biosynthetic process 5.20E-18
GO:0016043~cellular component organization and 
biogenesis
1.61E-11
GO:0033036~macromolecule localization 2.59E-09
GO:0045184~establishment of protein localization 8.07E-09
GO:0051236~establishment of RNA localization 1.36E-08
GO:0051649~establishment of cellular localization 5.39E-08
GO:0051641~cellular localization 6.48E-08
GO:0051301~cell division 1.12E-06
GO:0009056~catabolic process 1.25E-04
GO:0007049~cell cycle 2.38E-04
GO:0009719~response to endogenous stimulus 4.92E-04
GO:0022402~cell cycle process 2.11E-03
M v B (15) GO:0006412~translation 3.01E-21
GO:0009058~biosynthetic process 9.93E-21
GO:0044237~cellular metabolic process 4.03E-15
GO:0006396~RNA processing 4.06E-13
GO:0044238~primary metabolic process 8.43E-13
GO:0033036~macromolecule localization 3.53E-12
GO:0016043~cellular component organization and 
biogenesis
9.61E-10
GO:0045184~establishment of protein localization 1.35E-09
GO:0043170~macromolecule metabolic process 1.03E-08
GO:0051641~cellular localization 5.79E-08
GO:0051649~establishment of cellular localization 2.05E-07
GO:0006091~generation of precursor metabolites and 
energy
1.36E-06
GO:0051236~establishment of RNA localization 2.51E-05
GO:0009056~catabolic process 9.86E-05
GO:0051301~cell division 1.37E-03
Classification of GO of Biological Process was done with DAVID using the genes identified over-represented between each adjacent stage for 
mouse. P value less than 0.01 was identified as significant. The number in the bracket represents the count of significant GO terms.
Table 2: The over-represented classification of GO annotations for mouse identified genes (Continued)He et al. Reproductive Biology and Endocrinology 2010, 8:41
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Table 3: The over-represented classification of GO annotations for human identified genes
GO p value
1 v 2
(4)
GO:0051301~cell division 1.92E-03
GO:0044237~cellular metabolic process 3.40E-03
GO:0006396~RNA processing 6.67E-03
GO:0022402~cell cycle process 8.89E-03
2 v 4
(4)
GO:0044238~primary metabolic process 1.67E-03
GO:0044237~cellular metabolic process 2.92E-03
GO:0016265~death 5.13E-03
GO:0006396~RNA processing 8.17E-03
4 v 8
(23)
GO:0043170~macromolecule metabolic process 2.72E-45
GO:0044238~primary metabolic process 1.47E-38
GO:0044237~cellular metabolic process 2.95E-34
GO:0006396~RNA processing 7.68E-27
GO:0016043~cellular component organization and 
biogenesis
1.00E-25
GO:0019222~regulation of metabolic process 2.41E-18
GO:0050794~regulation of cellular process 3.30E-18
GO:0010468~regulation of gene expression 1.21E-17
GO:0006350~transcription 2.63E-17
GO:0007049~cell cycle 7.90E-16
GO:0051301~cell division 4.09E-15
GO:0033036~macromolecule localization 6.39E-14
GO:0050789~regulation of biological process 1.18E-12
GO:0045184~establishment of protein localization 1.36E-11
GO:0051236~establishment of RNA localization 5.45E-11
GO:0022402~cell cycle process 5.56E-10
GO:0051649~establishment of cellular localization 1.10E-07
GO:0007059~chromosome segregation 2.18E-07
GO:0051641~cellular localization 5.55E-07
GO:0006412~translation 4.44E-05
GO:0051656~establishment of organelle localization 5.55E-04
GO:0006376~mRNA splice site selection 1.24E-03
GO:0016265~death 5.38E-03
8 v M
(21)
GO:0044238~primary metabolic process 6.11E-25
GO:0044237~cellular metabolic process 2.20E-24
GO:0043170~macromolecule metabolic process 4.54E-19
GO:0016043~cellular component organization and 
biogenesis
3.52E-10
GO:0006412~translation 5.04E-08
GO:0006396~RNA processing 1.20E-06
GO:0051236~establishment of RNA localization 2.12E-06He et al. Reproductive Biology and Endocrinology 2010, 8:41
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GO:0007049~cell cycle 4.24E-06
GO:0009058~biosynthetic process 7.48E-06
GO:0009719~response to endogenous stimulus 7.65E-06
GO:0022402~cell cycle process 1.01E-05
GO:0033036~macromolecule localization 1.21E-05
GO:0045184~establishment of protein localization 6.87E-05
GO:0009056~catabolic process 7.37E-04
GO:0007059~chromosome segregation 7.54E-04
GO:0051301~cell division 1.01E-03
GO:0051649~establishment of cellular localization 3.81E-03
GO:0019222~regulation of metabolic process 3.92E-03
GO:0019748~secondary metabolic process 3.97E-03
GO:0051641~cellular localization 4.23E-03
GO:0050794~regulation of cellular process 5.35E-03
M v B
(21)
GO:0044238~primary metabolic process 6.38E-14
GO:0044237~cellular metabolic process 1.65E-13
GO:0043170~macromolecule metabolic process 5.25E-09
GO:0016043~cellular component organization and 
biogenesis
6.25E-08
GO:0033036~macromolecule localization 2.08E-07
GO:0050794~regulation of cellular process 7.93E-07
GO:0045184~establishment of protein localization 4.81E-06
GO:0050789~regulation of biological process 6.99E-06
GO:0051641~cellular localization 3.08E-05
GO:0051649~establishment of cellular localization 6.51E-05
GO:0010468~regulation of gene expression 1.68E-04
GO:0019222~regulation of metabolic process 2.30E-04
GO:0016265~death 4.69E-04
GO:0006396~RNA processing 5.29E-04
GO:0007049~cell cycle 6.10E-04
GO:0006350~transcription 1.46E-03
GO:0022402~cell cycle process 1.71E-03
GO:0051301~cell division 5.49E-03
GO:0009058~biosynthetic process 5.64E-03
GO:0048468~cell development 6.89E-03
GO:0009056~catabolic process 9.26E-03
Classification of GO of Biological Process was done with DAVID using the genes identified over-represented between each adjacent stage for 
human. P value less than 0.01 was identified as significant. The number in the bracket represents the count of significant GO terms.
Table 3: The over-represented classification of GO annotations for human identified genes (Continued)
human focused on such as "cell division", "cellular meta-
bolic process", "primary metabolic process" and "RNA
processing". These were all obtained for mouse, except
for the GO term "death". Just like to be delayed, most of
previous GO terms for mouse were appearing from 4-cell
to 8-cell stage for human, such as "macromolecule meta-
bolic process", "macromolecule localization", "establish-
ment of protein localization" and "establishment of RNA
localization". These findings support the idea that mid-
preimplantation gene activation (MGA) drives the overt
morphological changes in the subsequent stages, com-
paction and bifurcation into two-cell lineages. With theHe et al. Reproductive Biology and Endocrinology 2010, 8:41
http://www.rbej.com/content/8/1/41
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preparation of basic cellular machinery, dramatic biologi-
cal processes were happening during Human Phase 3
(morula and blastocyst), which is related to the event of
implantation.
Briefly, through our pathway analysis, most of the iden-
tified pathways were involved in after human 4-cell stage,
but the number of identified pathways shared in mouse
pre-implantation development. Moreover, many of the
features and signaling pathways that are required during
human pre-implantation development are also active
during tumourigenesis [27]. According to our analysis
based on human data, p53 signaling pathway, the path-
ways of Eenteropathogenic E. coli (EPEC) infection and
Enterohemorrhagic E. coli (EHEC) infection were identi-
fied separately in 4-cell and 8-cell stages. These pathways
were also thought to be related to the formation of cancer
and the regulation of human reproduction [28-31]. But
these above pathways were not identified from microar-
ray analysis in mouse 4-cell and 8-cell stages. On the con-
trary, the pathway of oxidative phosphorylation was
mostly identified through mouse pre-implantation devel-
opment, which hardly appeared in human data. The oxi-
dative phosphorylation pathway was reported as one of
the obligatory energy metabolism pathways in most spe-
cies throughout pre-implantation development [32]. And
the pathway of Citrate cycle (TCA cycle) was identified
after mouse 8-cell stage, which was not identified in
human data. It is well know that the mitochondrial TCA
cycle is the major source of reducing equivalents in the
cytosol so that any change in mitochondrial function in
the embryo will be reflected in changes in the intracellu-
lar redox state. In the mouse, the metabolic substrates
used by the oocyte and early embryo each have a different
impact on the intracellular redox state [33]. Surprisingly,
the common identified pathway from 4-cell to 8-cell stage
between human and mouse was only the Ubiquitin medi-
ated proteolysis pathway, which was reported as an
important role in eukaryotic cellular processes [34]. Thus
it is advisable to choose the Ubiquitin mediated proteoly-
sis pathway as the candidate pathway for further study on
reproductive biology and regenerative medicine using
mouse model. Interestingly, some of the known meta-
bolic pathways e.g. biosynthesis of steroids pathway and
fatty acid metabolism pathway were shown significant in
both human and mouse blastocysts. All of these suggest
that unlike in mouse, of which most of pathways found
were related to energy, RNA and protein metabolism, the
identified pathways in human were mostly disease-
related and associated with human pre-implantation
embryonic development. By contrast, there are some
common metabolic pathways participate in regulating the
mammal early embryonic development.
Furthermore, in view of the fact that many researchers
working in mice interpret their results in relation to
human reproduction, mice and human reproduction dif-
fer distinctly in many aspects; e.g. the reproduction in
mice is characterized by a very short oestrus cycle and
thus, displays a distinctly different endocrine dynamic
pattern if compared with humans or domestic animals
[35-38]. On the other hand, due to the difference in the
inner environment of embryo and the external environ-
ment of uterus, there are species differences in the
implantation process between mice and human [39-41].
The same applies for the regulatory mechanisms of early
embryonic development that can be not simply transfer-
able to the human species.
In sum, pre-implantation development involves a num-
ber of biologically significant events, such as compaction
and blastocyst formation, which represent morphologi-
cally dynamic changes, especially for mouse and human
[27]. Although the models of mouse have been well
examined, molecular mechanisms regulating the early
embryo development of human have been scarcely
reported and the credibility of using the mouse model to
explain the regulatory mechanism of human pre-implan-
tation development remains unclear. Briefly, in this study,
we have shown differences between mouse and human
pre-implantation developments both in the global gene
expression pattern and the expression changes of individ-
ual genes at each stage, including different major tran-
sient waves of transcription profiles and some stage-
specific genes and pathways. Undeniably, Studies in mice
have provided insights into the molecular basis of human
pre-implantation development because of their shared
features. In both species, early embryo development leads
to a complex regulatory mechanism. However, the nature
of human embryonic signals that influence uterine func-
tions is more difficult than rodents', especially at the later
stages of pre-implantation development (morula and
blastocyst). Thus, it limits the availability of adequate
amounts of tissues for mouse analysis. Moreover, the
quality and quantity of samples chosen in microarray
experiments also play essential roles in effecting the accu-
racy of mouse model, especially the conditions for in
vitro maturation and fertilization are crucial for the
proper early embryo development and may result in
developmental aberrations.
Conclusions
By comparison between mouse and human expression
profiles, we have noted that the regulatory mechanism of
human pre-implantation development is different from
the mouse, and even more complex. Through our analy-
sis, we have found differences between mouse and human
transcription profiles both in the global expression pat-
tern of genes and in expression of individual genes within
the gene clusters identified and in the significantly related
pathways. Not as the fact that 1-cell to 2-cell stage isHe et al. Reproductive Biology and Endocrinology 2010, 8:41
http://www.rbej.com/content/8/1/41
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Table 4: The over-represented classification of pathways for mouse identified genes
pathways p value
1 v 2
(10)
mmu03010:Ribosome 1.25E-40
mmu04120:Ubiquitin mediated proteolysis 4.56E-08
mmu00240:Pyrimidine metabolism 6.90E-06
mmu00230:Purine metabolism 8.55E-05
mmu04110:Cell cycle 1.25E-04
mmu03050:Proteasome 2.07E-04
mmu03020:RNA polymerase 3.18E-03
mmu04115:p53 signaling pathway 3.71E-03
mmu00190:Oxidative phosphorylation 3.87E-03
mmu03030:DNA polymerase 7.14E-03
2 v 4
(7)
mmu03010:Ribosome 2.02E-39
mmu03050:Proteasome 3.67E-09
mmu04110:Cell cycle 6.60E-04
mmu00040:Pentose and glucuronate interconversions 1.93E-03
mmu00190:Oxidative phosphorylation 3.33E-03
mmu00230:Purine metabolism 4.03E-03
mmu00500:Starch and sucrose metabolism 9.65E-03
4 v 8
(5)
mmu03010:Ribosome 2.50E-08
mmu03050:Proteasome 4.84E-07
mmu00190:Oxidative phosphorylation 2.41E-05
mmu04120:Ubiquitin mediated proteolysis 2.63E-03
mmu00020:Citrate cycle (TCA cycle) 3.94E-03
8 v M
(10)
mmu03010:Ribosome 1.01E-25
mmu03050:Proteasome 2.73E-13
mmu00240:Pyrimidine metabolism 2.26E-10
mmu03020:RNA polymerase 1.23E-08
mmu04110:Cell cycle 1.97E-07
mmu00230:Purine metabolism 1.36E-05
mmu00500:Starch and sucrose metabolism 4.42E-04
mmu04120:Ubiquitin mediated proteolysis 6.82E-04
mmu00040:Pentose and glucuronate interconversions 8.00E-04
mmu00190:Oxidative phosphorylation 4.44E-03
M v B
(9)
mmu03010:Ribosome 4.82E-19
mmu00190:Oxidative phosphorylation 2.53E-16
mmu03050:Proteasome 1.17E-09
mmu00280:Valine, leucine and isoleucine degradation 6.28E-06
mmu00020:Citrate cycle (TCA cycle) 1.21E-05
mmu04110:Cell cycle 5.17E-04
mmu00100:Biosynthesis of steroids 3.50E-03
mmu00071:Fatty acid metabolism 3.50E-03
mmu00281:Geraniol degradation 4.47E-03
Classification of related pathways was done with DAVID using the genes identified over-represented between each adjacent stage for mouse. 
P value less than 0.01 was identified as significant. The number in the bracket represents the count of significant pathways.He et al. Reproductive Biology and Endocrinology 2010, 8:41
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Table 5: The over-represented classification of pathways for human identified genes
pathways p value
1 v 2
(0)
none none
2 v 4
(3)
hsa04540:Gap junction 2.29E-03
hsa00100:Biosynthesis of steroids 2.84E-03
hsa05060:Prion disease 4.75E-03
4 v 8
(8)
hsa04110:Cell cycle 3.37E-09
hsa04120:Ubiquitin mediated proteolysis 1.44E-07
hsa04520:Adherens junction 5.58E-06
hsa04115:p53 signaling pathway 2.87E-04
hsa03022:Basal transcription factors 8.31E-04
hsa00230:Purine metabolism 4.87E-03
hsa05215:Prostate cancer 4.99E-03
hsa00970:Aminoacyl-tRNA biosynthesis 8.41E-03
8 v M
(6)
hsa04120:Ubiquitin mediated proteolysis 9.93E-05
hsa04110:Cell cycle 1.58E-04
hsa05131: Eenteropathogenic E. coli 
(EPEC) infection
3.82E-03
hsa05130: Enterohemorrhagic E. coli 
(EHEC) infection
3.82E-03
hsa04115:p53 signaling pathway 3.93E-03
hsa05221:Acute myeloid leukemia 7.63E-03
M v B
(11)
hsa00100:Biosynthesis of steroids 2.26E-06
hsa05131: Eenteropathogenic E. coli 
(EPEC) infection
5.82E-05
hsa05130: Enterohemorrhagic E. coli 
(EHEC) infection
5.82E-05
hsa04120:Ubiquitin mediated proteolysis 1.78E-04
hsa00251:Glutamate metabolism 3.03E-04
hsa04520:Adherens junction 7.05E-04
hsa00071:Fatty acid metabolism 2.75E-03
hsa05110:Cholera - Infection 2.93E-03
hsa00280:Valine, leucine and isoleucine 
degradation
6.04E-03
hsa05211:Renal cell carcinoma 6.26E-03
hsa00900:Terpenoid biosynthesis 7.14E-03
Classification of related pathways was done with DAVID using the genes identified over-represented between each adjacent stage for 
human. P value less than 0.01 was identified as significant. The number in the bracket represents the count of significant pathways.He et al. Reproductive Biology and Endocrinology 2010, 8:41
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important for mouse pre-implantation development, the
4-cell stage and 8-cell stage are both essential for human.
Unlike in mouse, of which most of pathways found were
related to energy, RNA and protein metabolism, the iden-
tified pathways in human were mostly disease-related and
associated with human pre-implantation embryonic
development. Different expression patterns and signifi-
cantly related biological processes during each stage
between mouse and human suggest that a further com-
parative analysis should be required for applying the
result of mouse expression data to human research or
therapy, particularly in pre-implantation developments.
Our study also provides several potential targets of genes
and pathways for studying the regulatory mechanism of
human pre-implantation development using mouse
model, such as the gene of Xist and the Ubiquitin medi-
ated proteolysis pathway.
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